Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data

ABSTRACT:

SUBMITTER: Choi J 

PROVIDER: S-EPMC10713275 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature